Pfizer, U.S. ink $5.29B deal for possible COVID-19 treatment




  • In Health
  • 2021-11-18 12:48:42Z
  • By Associated Press
 

NEW YORK (AP) - The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators approve it.

Pfizer asked the Food and Drug Administration on Tuesday to authorize the experimental pill, which has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections.

The FDA is already reviewing a competing pill from Merck and will hold a public meeting on it later this month.

The price for Pfizer's potential treatment amounts to about $529 per course. The U.S. has already agreed to pay roughly $700 per course of Merck's drug for about 1.7 million treatments.

Pfizer said Thursday the price being paid by the U.S. government reflects the high number of treatment courses purchased through 2022.

Pfizer reported earlier this month that its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms of COVID-19. The company studied its pill in people who were unvaccinated and faced the worst risks from the virus due to age or health problems, such as obesity.

COMMENTS

More Related News

Sputnik V shows higher Omicron-antibody levels than Pfizer in preliminary study
Sputnik V shows higher Omicron-antibody levels than Pfizer in preliminary study
  • US
  • 2022-01-20 15:31:34Z

A small preliminary laboratory study has shown that levels of Omicron-neutralising antibodies of people vaccinated with Russia's Sputnik V vaccine did not...

One chart shows people vaccinated with Moderna had the best protection against COVID in 2021
One chart shows people vaccinated with Moderna had the best protection against COVID in 2021

The huge new CDC dataset backs up what other studies have found, that Moderna is edging out Pfizer and J&J is offering less protection against COVID.

Africa CDC says it will talk to Merck about COVID pill, Pfizer talks
Africa CDC says it will talk to Merck about COVID pill, Pfizer talks 'advanced'
  • US
  • 2022-01-20 09:30:11Z

The Africa Centres for Disease Control and Prevention (CDC) had announced last week it was negotiating for supplies of Paxlovid, joining a global race for a ...

65,000 COVID Cases Confirmed At LA County Schools
65,000 COVID Cases Confirmed At LA County Schools

Back-to-school testing last week uncovered tens of thousands of COVID cases, and overall hospitalizations and deaths are climbing.

FDA adds all blood sample collection tubes to medical device shortage list
FDA adds all blood sample collection tubes to medical device shortage list
  • US
  • 2022-01-19 21:41:59Z

The Food and Drug Administration also advised healthcare and laboratory personnel to minimize the use of blood collection tubes by performing blood draws...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Health